Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy - Trouble starts on day 3

Journal of Diabetes Science and Technology

Volumn 4, Issue 4, 2010, Pages 976-982

  Schmid, Volkmar ^a   Hohberg, Cloth ^b   Borchert, Marcus ^a   Forst, Thomas ^b   Pfuẗzner, Andreas ^b  

^a IKFE CRO   (Germany)

^b IKFE Institute for Clinical Research and Development   (Germany)

Author keywords

Catheter infusion set; CSII; Duration of use; Infusion set failure; Insulin pump therapy

Indexed keywords

POLITEF;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CATHETERIZATION; CLINICAL TRIAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INJURY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; PILOT STUDY; PROSPECTIVE STUDY; QUESTIONNAIRE; SKIN;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CATHETERIZATION; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN INFUSION SYSTEMS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PILOT PROJECTS; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SKIN; YOUNG ADULT;

EID: 78049488149     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400429     Document Type: Article

References (23)

1. Pfützner A, Berger S, Spinas GA. Aktueller stellenwert der kontinuierlichen subkutanen Insulininfusion (CSII) mit Insulinpumpen in der therapie des diabetes mellitus (Actual value of CSII in the therapy of diabetes mellitus). Swiss Med Weekly. 2000;130:1954-61.
2. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26(4):1079-87.
3. Pickup JC, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care. 2008;31 Suppl. 2:S140-5.
4. Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, Fradin S, Reznik Y. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39(3):224-9.
5. Scheiner G, Sobel RJ, Smith DE, Pick AJ, Kruger D, King J, Green K. Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ. 2009;35 Suppl. 2:29S-41S.
6. Hoogma RP, Schumicki D. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Horm Metab Res. 2006;38(6):429-33.
7. Renner R, Pfützner A, Trautmann M, Harzer O, Sauter K, Landgraf R. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. Diabetes Care. 1999;22(5):784-8.
8. Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care. 2005;28(3):533-8.
9. Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev. 2009;25(2):99-111.
10. Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, Lavent F. A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump. J Diabetes Complications. 2001;15(6):295-300.
11. Nguyen TV, Burnett JW. Local skin reaction caused by the plastic catheter tubing of the continuous subcutaneous insulin infusion system. Cutis. 1988;41(5):355-6.
12. Levandoski LA, White NH, Santiago JV. Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy. Diabetes Care. 1982;5 Suppl 1:6-10.
13. Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661-7.
14. Højbjerre L, Skov-Jensen C, Kaastrup P, Pedersen PE, Stallknecht B. Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans. Diabetes Technol Ther. 2009;11(5):301-6.
15. Clausen TS, Kaastrup P, Stallknecht B. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diabetes Technol Ther. 2009;11(9):575-80.
16. Kerr D, Morton J, Whately-Smith C, Everett J, Begley JP. Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates. J Diabetes Sci Technol. 2008;2(3):450-5.
17. Poulsen C, Langkjaer L, Worsøe C. Precipitation of insulin products used forcontinuous subcutaneous insulin infusion. Diabetes Technol Ther. 2005;7(1):142-50.
18. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006;23(2):141-7.
19. Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care. 2000;23(9):1232-5.
20. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300(11):573-8.
21. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161(19):2293-300.
22. Jolanki R, Kanerva L, Estlander T, Henriks-Eckerman ML, Suhonen R. Allergic contact dermatitis from phenoxyethoxy ethylacrylates in optical fiber coating, and glue in an insulin pump set. Contact Derm. 2001;45(1):36-7.
23. Nowakowska M, Jarosz-Chobot P, Polańska J, Machnica Ł. Bacterial strains colonizing subcutaneous catheters of personal insulin pumps. Pol J Microbiol. 2007;56(4):239-43.